Please use this identifier to cite or link to this item:
Title: Liver tumor models in transgenic zebrafish: An alternative in vivo approach to study hepatocarcinogenes
Authors: Huang, X.
Zhou, L.
Gong, Z. 
Keywords: anticancer drug
drug screening
hepatocellular carcinoma
Issue Date: Jan-2012
Citation: Huang, X., Zhou, L., Gong, Z. (2012-01). Liver tumor models in transgenic zebrafish: An alternative in vivo approach to study hepatocarcinogenes. Future Oncology 8 (1) : 21-28. ScholarBank@NUS Repository.
Abstract: The small vertebrate, zebrafish, has generated a big wave in current biomedical research. In the early experiments of carcinogen treatment, it has been found that the induced tumors in the zebrafish share many similar features with those of humans. With the recent development in transgenic technology, we are able to control the expression of a specific oncogene in targeted organs for generation of different tissue tumor models in zebrafish. In particular, the fusion of an oncogene and a color reporter, such as the green fluorescent protein, allows us to conveniently monitor transgenic tumors for their initiation, progression, metastasis and transplantation in the transparent zebrafish embryos, as demonstrated in this article with our newly established liver cancer models. What does the future hold in this rapidly growing model organism? Other than understanding the molecular mechanisms of carcinogenesis, one obvious area will be the potential of these models for rapid and high-throughput screening for anticancer drugs. © 2012 Future Medicine Ltd.
Source Title: Future Oncology
ISSN: 14796694
DOI: 10.2217/fon.11.137
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.